Question 1

CRS HIPEC

Accepted Answer

Surgical management and hyperthermic intraperitoneal chemotherapy for locally advanced colorectal cancer
Hematological toxicities associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Novel prognostic score for outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with metachronous peritoneal carcinomatosis
The importance of synchronicity in the management of colorectal peritoneal metastases with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
High‑grade complication is associated with poor overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
A set of molecular markers predicts chemosensitivity to Mitomycin-C following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis
P.R.O.P.S. — A novel Pre-Operative Predictive Score for unresectability in patients with colorectal peritoneal metastases being considered for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
Biphasic learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy:technical competence and refinement of patient selection
Early recurrence after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastrointestinal cancers: fad or standard of care?
The impact of urological resection and reconstruction on patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
Are positron emission tomography-computed tomography (PET-CT) scans useful in preoperative assessment of patients with peritoneal disease before cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)?
Does having a gastrectomy delay time to feeding and prolong hospital stay in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?
CA-125: an inaccurate surveillance tool immediately after cytoreductive surgery and hyperthermic intraoperative chemotherapy (CRS-HIPEC)?
Exploring the trend in referrals for consideration of CRS and HIPEC to understand the attitudes of clinicians in the development of a national cancer centre programme in peritoneal disease
Platinum agents and mitomycin C specific complications in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
Acute Kidney Injury In Ovarian Cancer Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Uncommon indications for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in recurrent ovarian cancer with peritoneal metastasis: a prospective registry study on 41 patients
Preoperative platelet–lymphocyte ratio is an independent prognostic marker and superior to carcinoembryonic antigen in colorectal peritoneal carcinomatosis patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Surgical Management of Metastatic Colorectal Cancer: A Single-Centre Experience on Oncological Outcomes of Pulmonary Resection vs Cytoreductive Surgery and HIPEC
Morbidity and Mortality of Elderly Patients Following Cytoreductive Surgery and HIPEC
Does early post-operative intraperitoneal chemotherapy (EPIC) for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) make a difference?
Colorectal peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: The experience of a tertiary Asian center
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Asian Patients: 100 Consecutive Patients in a Single Institution

Question 2

Rectal Cancer

Accepted Answer

Management of synchronous lateral pelvic nodal metastasis in rectal cancer in the era of neoadjuvant chemoradiation: A systemic review
Role of Pelvic Exenteration in the Management of Locally Advanced Primary and Recurrent Rectal Cancer

Question 3

Colorectal Cancer

Accepted Answer

Post-operative inflammatory marker surveillance in colorectal peritoneal carcinomatosis
Can sidedness predict for survival in primary locoregional colon cancers?
Malignancy arising in a 41-year-old colonic interposition graft
Surgical Management of Colorectal Peritoneal Metastases: Treatment and Outcomes Compared with Hepatic Metastases

Question 4

Sarcoma

Accepted Answer

Axillary Lymph Node Dissection in Angiosarcomas of the Breast: An Asian Institutional Perspective
Two Cancers Arising from Different Mesenchymal Origins: An Unexpected Connection over Time and Space
The Approach to Solitary Fibrous Tumors: Are Clinicopathological Features and Nomograms Accurate in the Prediction of Prognosis?
Regional Lymph Node Metastases in Groin Sarcomas: A Diagnostic and Therapeutic Challenge
Radiation-associated peritoneal angiosarcoma
A solitary fibrous tumour mimicking an aggressive angiomyxoma/liposarcoma
Tumor biology remains the main determinant of prognosis in retroperitoneal sarcomas: A 14-year single-center experience
Is the Memorial Sloan Kettering Cancer Centre (MSKCC) sarcoma nomogram useful in an Asian population?

Question 5

Melanoma

Accepted Answer

Treatment and outcomes of melanoma in Asia: Results from the National Cancer Centre Singapore
Clinical patterns and management of primary mucosal melanoma: a single centre experience

Question 6

Gastric Cancer

Accepted Answer

Metastatic gastric cancer: Does the site of metastasis make a difference?
Today's Research, Tomorrow's Cure
Gastric peritoneal carcinomatosis - A retrospective review
Is multivisceral resection in locally advanced gastrointestinal stromal tumours an acceptable strategy?: Multivisceral resection in GISTs
A case of portomesenteric venous gas found with extensive secondary pneumatosis intestinalis in the small bowel, stomach and distal oesophagus on radiographic images with an insidious presentation

Question 7

Ovarian Cancer

Accepted Answer

Palliative surgery for Krukenberg tumors – 12-year experience and review of the literature
Relevance of enlarged cardiophrenic lymph nodes in determining prognosis of patients with advanced ovarian cancer

Question 8

Cervical Cancer

Accepted Answer

Novel management of a giant cervical myoma in a premenopausal patient

Question 9

Appendix Cancer

Accepted Answer

Diagnostic and therapeutic laparoscopy in assessment and management of patients with appendiceal neoplasms
Two rare cases of appendiceal collision tumours involving an appendiceal mucinous neoplasm and carcinoid

Question 10

Peritoneal Cancer

Accepted Answer

Proposed radiological criteria for pre-operative determination of resectability in peritoneal-based malignancies
Prognostic Relevance of the Peritoneal Surface Disease Severity Score Compared to the Peritoneal Cancer Index for Colorectal Peritoneal Carcinomatosis

Question 11

Miscellaneous

Accepted Answer

Revision of loop colostomy under regional anaesthesia and sedation
Exosome-templated nanoplasmonics for multiparametric molecular profiling

MELISSA TEO SURGERY &
THE SURGICAL ONCOLOGY CLINIC

PUBLISHED PAPERS

CRS HIPEC

Rectal Cancer

Colorectal Cancer

Sarcoma

Melanoma

Gastric Cancer

Ovarian Cancer

Cervical Cancer

Appendix Cancer

Peritoneal Cancer

Miscellaneous

©2019 - 2023 by Melissa Teo Surgery & The Surgical Oncology Clinic

MELISSA TEO SURGERY & THE SURGICAL ONCOLOGY CLINIC

PUBLISHED PAPERS

CRS HIPEC

Rectal Cancer

Colorectal Cancer

Sarcoma

Melanoma

Gastric Cancer

Ovarian Cancer

Cervical Cancer

Appendix Cancer

Peritoneal Cancer

Miscellaneous

©2019 - 2023 by Melissa Teo Surgery & The Surgical Oncology Clinic

MELISSA TEO SURGERY &
THE SURGICAL ONCOLOGY CLINIC